DARIA KACPRZYK: Open Payments
NPI 1811463912 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 48 payments from 14 companies in 2025. Trend: 2023 $876 · 2024 $1,357 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 9 | $270 |
| Gilead Sciences, Inc. | 8 | $183 |
| Novo Nordisk Inc | 6 | $134 |
| ABBVIE INC. | 6 | $129 |
| Lilly USA, LLC | 5 | $102 |
| PFIZER INC. | 4 | $90 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Boston Scientific Corporation | 2 | $51 |
| Bausch Health US, LLC | 1 | $33 |
| SANOFI PASTEUR INC. | 1 | $31 |
Products named: APRETUDE, MOUNJARO, NURTEC ODT, Wegovy, QULIPTA, GARDASIL 9, UBRELVY, Ozempic.
Industry payments across NY — which companies pay providers there.
